These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 19686530

  • 1. Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment.
    Hajek P, Tønnesen P, Arteaga C, Russ C, Tonstad S.
    Addiction; 2009 Sep; 104(9):1597-602. PubMed ID: 19686530
    [Abstract] [Full Text] [Related]

  • 2. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
    Hajek P, McRobbie HJ, Myers KE, Stapleton J, Dhanji AR.
    Arch Intern Med; 2011 Apr 25; 171(8):770-7. PubMed ID: 21518946
    [Abstract] [Full Text] [Related]

  • 3. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C, Xiao D, Chan KP, Pothirat C, Garza D, Davies S.
    Respirology; 2009 Apr 25; 14(3):384-92. PubMed ID: 19192221
    [Abstract] [Full Text] [Related]

  • 4. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG, Gitchell JG, Shiffman S, Sembower MA.
    Clin Ther; 2009 Sep 25; 31(9):1957-65. PubMed ID: 19843485
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of a flexible quit date versus an a priori quit date approach to smoking cessation: a cross-study analysis.
    Hughes JR, Russ CI, Arteaga CE, Rennard SI.
    Addict Behav; 2011 Dec 25; 36(12):1288-91. PubMed ID: 21872998
    [Abstract] [Full Text] [Related]

  • 6. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR.
    Arch Intern Med; 2011 Dec 25; 166(15):1561-8. PubMed ID: 16908788
    [Abstract] [Full Text] [Related]

  • 7. Varenicline in the management of smoking cessation: a single technology appraisal.
    Hind D, Tappenden P, Peters J, Kenjegalieva K.
    Health Technol Assess; 2009 Sep 25; 13 Suppl 2():9-13. PubMed ID: 19804684
    [Abstract] [Full Text] [Related]

  • 8. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S.
    Clin Ther; 2008 Aug 25; 30(8):1461-75. PubMed ID: 18803988
    [Abstract] [Full Text] [Related]

  • 9. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S, Patel PN.
    Cardiol Rev; 2007 Aug 25; 15(3):154-61. PubMed ID: 17438382
    [Abstract] [Full Text] [Related]

  • 10. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
    Bolliger CT, Issa JS, Posadas-Valay R, Safwat T, Abreu P, Correia EA, Park PW, Chopra P.
    Clin Ther; 2011 Apr 25; 33(4):465-77. PubMed ID: 21635992
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, Anziano R, Reeves K.
    Arch Intern Med; 2011 Apr 25; 166(15):1571-7. PubMed ID: 16908789
    [Abstract] [Full Text] [Related]

  • 12. Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
    Gonzales D, Jorenby DE, Brandon TH, Arteaga C, Lee TC.
    Addiction; 2010 Nov 25; 105(11):2002-13. PubMed ID: 20819082
    [Abstract] [Full Text] [Related]

  • 13. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
    Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR, Varenicline Phase 3 Study Group.
    JAMA; 2006 Jul 05; 296(1):64-71. PubMed ID: 16820548
    [Abstract] [Full Text] [Related]

  • 14. The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data.
    Fagerström K, Russ C, Yu CR, Yunis C, Foulds J.
    Nicotine Tob Res; 2012 Dec 05; 14(12):1467-73. PubMed ID: 22467778
    [Abstract] [Full Text] [Related]

  • 15. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
    Stapleton JA, Watson L, Spirling LI, Smith R, Milbrandt A, Ratcliffe M, Sutherland G.
    Addiction; 2008 Jan 05; 103(1):146-54. PubMed ID: 18028247
    [Abstract] [Full Text] [Related]

  • 16. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP.
    J Clin Psychiatry; 2012 May 05; 73(5):654-60. PubMed ID: 22697191
    [Abstract] [Full Text] [Related]

  • 17. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM, Diacon AH, van Biljon X, Bolliger CT.
    Addiction; 2004 May 05; 99(5):634-40. PubMed ID: 15078238
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of varenicline for smoking cessation.
    Hays JT, Ebbert JO, Sood A.
    Am J Med; 2008 Apr 05; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [Abstract] [Full Text] [Related]

  • 19. Varenicline in smoking cessation.
    Tonstad S, Rollema H.
    Expert Rev Respir Med; 2010 Jun 05; 4(3):291-9. PubMed ID: 20524911
    [Abstract] [Full Text] [Related]

  • 20. Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline.
    Steinberg MB, Randall J, Greenhaus S, Schmelzer AC, Richardson DL, Carson JL.
    Addict Behav; 2011 Dec 05; 36(12):1127-32. PubMed ID: 21835552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.